A phase I combination study of GMCSF/bi-shRNA(furin) DNA-transfected autologous tumor immunotherapy and atezolizumab - In Conclusion - Rodney Paul Rocconi MD University of South Alabama @...

A phase I combination study of GMCSF/bi-shRNA(furin) DNA-transfected autologous tumor immunotherapy and atezolizumab - In Conclusion - Rodney Paul Rocconi MD University of South Alabama @...

User Photo
Cancer-News

3 weeks
5 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Rodney Paul Rocconi, MD University of South Alabama discusses A phase I combination study of GMCSF/bi-shRNA(furin) DNA-transfected autologous tumor immunotherapy and atezolizumab in recurrent/refractory advanced-stage ovarian cancer: Efficacy assessment in BRCA1/2-wt patients

ASCO

https://meetinglibrary.asco.org/record/185052/abstract
Up Next Autoplay